Seattle Sperm Bank – FDA 483, Jun 12, 2025
An FDA inspection of Seattle Sperm Bank in Denver, CO, revealed two significant observations related to the handling of human cells, tissues, and cellular and tissue-based products (HCT/Ps) from ineligible donors. The firm failed to properly label HCT/Ps from ineligible donors with biohazard warnings and communicable disease risk statements, and also did not include required summary records detailing donor eligibility determinations when shipping these products. These issues indicate deficiencies in the firm's procedures for ensuring the safety and proper documentation of HCT/Ps.
- Office
- Denver District Office
- Person
ID · 9e3804bb-6ae6-408e-8f65-c2a317445f03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.